Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin:: A synergistic drug combination

被引:42
作者
Matsumura, S [1 ]
Simor, AE [1 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Microbiol, SD Lab Serv, N York, ON M4N 3M5, Canada
关键词
D O I
10.1086/517755
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1554 / 1556
页数:3
相关论文
共 7 条
[1]   INVITRO ACTIVITY OF RP 59500, A NEW SEMISYNTHETIC STREPTOGRAMIN ANTIBIOTIC, AGAINST GRAM-POSITIVE BACTERIA [J].
BRUMFITT, W ;
HAMILTONMILLER, JMT ;
SHAH, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 :29-37
[2]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27
[3]   Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to Enterococci with VanA/VanB resistance patterns [J].
Furlong, WB ;
Rakowski, TA .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (01) :163-164
[4]   Quinupristin-dalfopristin (RP 59500): An injectable streptogramin combination [J].
Griswold, MW ;
Lomaestro, BM ;
Briceland, LL .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (17) :2045-2053
[5]  
Moellering RC, 1998, CLIN INFECT DIS, V26, P1196, DOI 10.1086/520283
[6]  
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[7]  
Vijayvargiya R, 1996, J AM SOC NEPHROL, V7, P536